RPS6KA2
Ribosomal protein S6 kinase alpha-2
Also known as: HU-2, KS6A2_HUMAN, RSK3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15349
- Gene
- RPS6KA2
- Ensembl
- ENSG00000071242
- Chromosome
- 6
- Canonical length
- 733 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains two non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Alternative splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
733 residues, UniProt reviewed canonical sequence.
>Q15349|RPS6KA2
1 MDLSMKKFAV RRFFSVYLRR KSRSKSSSLS RLEEEGVVKE IDISHHVKEG FEKADPSQFE
61 LLKVLGQGSY GKVFLVRKVK GSDAGQLYAM KVLKKATLKV RDRVRSKMER DILAEVNHPF
121 IVKLHYAFQT EGKLYLILDF LRGGDLFTRL SKEVMFTEED VKFYLAELAL ALDHLHSLGI
181 IYRDLKPENI LLDEEGHIKI TDFGLSKEAI DHDKRAYSFC GTIEYMAPEV VNRRGHTQSA
241 DWWSFGVLMF EMLTGSLPFQ GKDRKETMAL ILKAKLGMPQ FLSGEAQSLL RALFKRNPCN
301 RLGAGIDGVE EIKRHPFFVT IDWNTLYRKE IKPPFKPAVG RPEDTFHFDP EFTARTPTDS
361 PGVPPSANAH HLFRGFSFVA SSLIQEPSQQ DLHKVPVHPI VQQLHGNNIH FTDGYEIKED
421 IGVGSYSVCK RCVHKATDTE YAVKIIDKSK RDPSEEIEIL LRYGQHPNII TLKDVYDDGK
481 FVYLVMELMR GGELLDRILR QRYFSEREAS DVLCTITKTM DYLHSQGVVH RDLKPSNILY
541 RDESGSPESI RVCDFGFAKQ LRAGNGLLMT PCYTANFVAP EVLKRQGYDA ACDIWSLGIL
601 LYTMLAGFTP FANGPDDTPE EILARIGSGK YALSGGNWDS ISDAAKDVVS KMLHVDPHQR
661 LTAMQVLKHP WVVNREYLSP NQLSRQDVHL VKGAMAATYF ALNRTPQAPR LEPVLSSNLA
721 QRRGMKRLTS TRLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RPS6KA2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 72 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 72 nTPM
- heart muscle: 58 nTPM
- parathyroid gland: 47 nTPM
- lung: 43 nTPM
- midbrain: 42 nTPM
- thyroid gland: 34 nTPM
Single-cell type
- lactotrophs: 1,055 nCPM
- bergmann glia: 1,047 nCPM
- thyrotrophs: 1,045 nCPM
- somatotrophs: 986 nCPM
- astrocytes: 833 nCPM
- retinal horizontal cells: 705 nCPM
Immune cell
- eosinophil: 22 nTPM
- plasmacytoid DC: 4.7 nTPM
- NK-cell: 4.4 nTPM
- non-classical monocyte: 2.2 nTPM
- intermediate monocyte: 0.8 nTPM
- myeloid DC: 0.8 nTPM
Brain region
- medulla oblongata: 114 nTPM
- white matter: 114 nTPM
- hypothalamus: 111 nTPM
- pons: 102 nTPM
- midbrain: 100 nTPM
- thalamus: 98 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 2.58
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- brain renin-angiotensin system
- cardiac muscle cell apoptotic process
- cellular response to carbohydrate stimulus
- chemical synaptic transmission
- heart contraction
- heart development
- intracellular signal transduction
- negative regulation of cell cycle
- negative regulation of cell population proliferation
- negative regulation of meiotic nuclear division
- oocyte maturation
- positive regulation of apoptotic process
- positive regulation of gene expression
- regulation of protein processing
- signal transduction
- TORC1 signaling
Molecular functions
- ATP binding
- magnesium ion binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- protein serine/threonine/tyrosine kinase activity
- ribosomal protein S6 kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- AGC-kinase, C-terminal
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Ribosomal protein S6 kinase II
- Protein kinase, ATP binding site
- Protein kinase, C-terminal
- Ribosomal S6 kinase, N-terminal catalytic domain
- Protein kinase domain
- Protein kinase C terminal domain
- RSK3, C-terminal catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RPS6KA2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RPS6KA2 as an antibody target. Whether an autoantibody or antibody against RPS6KA2 could matter depends on whether native RPS6KA2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RPS6KA2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RPS6KA2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...